
CPHI & PMEC China 2026
06/2026 – 06/2026
Established in 2011, Sichuan Qingmu Pharmaceuticals Co., Ltd. is mainly engaged in manufacturing APIs and advanced intermediates, with CMO/CDMO services also part of its business scope. Qingmu has obtained GMP certificates for 10 APIs, 3 J-MFs, 1 US DMF, 2 US VMFs and 1 CEP, and has passed USFDA site inspection.

Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen